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ABSTRACT
The 2G1MycP2Tu1 cell line was obtained following
transfection of human colon carcinoma cells from
the SW613-S cell line with a plasmid carrying a
genomic copy of the human MYC gene. 2G1Myc-
P2Tu1 cells produce MYC mRNAs and proteins of
abnormal size. In order to analyze the structure of
theseabnormalproducts,acDNAlibraryconstructed
using RNA isolated from these cells was screened
with a MYC probe. Fifty clones were studied by DNA
sequencing. The results indicated that a truncated
copy of the MYC gene had integrated into an rDNA
transcription unit in 2G1MycP2Tu1 cells. This was
confirmed by northern blot analysis, PCR ampli-
fication on genomic DNA and fluorescent in situ
hybridization (FISH) experiments on metaphase
chromosomes. 2G1MycP2Tu1 cells produce hybrid
rRNA-MYC RNA molecules that are polyadenylated
and processed by splicing reactions involving nat-
ural and cryptic splice sites. These transcripts are
synthesized by RNA polymerase I, as confirmed by
actinomycin D sensitivity experiments, suggesting
that 30 end processing and splicing are uncoupled
from transcription in this case. 2G1MycP2Tu1 cells
also produce another type of chimeric mRNAs con-
sisting of correctly spliced exons 2 and 3 of the MYC
gene fused to one or more extraneous 50 exons by
proper splicing to the acceptor sites of MYC exon 2.
These foreign exons belong to 33 different genes,
which are located on 14 different chromosomes.
These observations and the results of FISH and
Southern blotting experiments lead us to conclude
that trans-splicing events occur at high frequency
in 2G1MycP2Tu1 cells.
INTRODUCTION
Eukaryotic gene expression is a complex multi-step process
requiring several multi-component cellular machines. Each
machine carries out a separate step in the gene expression
pathway. For example, the maturation of eukaryotic mRNAs
that are synthesized by RNA polymerase II consists of the
addition of a cap structure at the 50 end of the mRNA, splicing
out of the introns, cleavage and polyadenylation at the 30 end
(1). Splicing and 30 end polyadenylation have been tradition-
ally viewed as post-transcriptional events. However, it has
emerged recently that these processing events are tightly
linked to transcription (2). The C-terminal domain of the
largest subunit of RNA polymerase II plays an important
role in coupling transcription with RNA processing. This
domain speciﬁcally binds the capping enzyme, splicing factors
and 30 end processing factors, thus targeting them to the nas-
cent transcripts. Nevertheless, a controversy persists as to the
requirement of RNA polymerase II for polyadenylation. It has
been reported that RNA polymerase I-generated transcripts
are polyadenylated in mouse 3T3 cells (3). Furthermore, it
seems that the polyadenylation machinery is able to function
independently of RNA polymerase II transcription inyeast (4).
In contrast, it has been shown that herpes simplex virus tk
mRNAs synthesized by RNA polymerase I are not poly-
adenylated in monkey COS-7 cells (5). Thus, it is still unclear
whether RNA polymerase II transcription is necessary for
polyadenylation and, more generally, for mRNA processing.
Although splicing reactions can occur independently of tran-
scription in reconstituted systems in vitro (albeit with a low
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uncoupling of splicing from RNA polymerase II-mediated
transcription in vivo. Splicing of RNA polymerase I transcripts
has been reported for protein-coding genes in Trypanosoma
brucei (6).
In the vast majority of cases, maturation of pre-mRNAs
occurs by splicing in cis. However, cases of maturation by
trans-splicing have been described, especially in trypano-
somes (7), nematodes (8) and Drosophila (9,10). In this latter
organism, trans-splicing is very important in generating pro-
tein diversity. In mammals, there are few examples of pre-
mRNA maturation by trans-splicing [(11–13) and references
therein]. For example, in the rat, the carnitin octanoyltrans-
ferase (COT) gene produces three different transcripts through
cis- and trans-splicing reactions (11). In any case, it seems that
trans-splicing always occurs in parallel with, and at a far lower
frequency than, cis-splicing (12). Furthermore, the existence
of proteins encoded by trans-spliced mRNAs has not been
reported in mammals, except in the case of the rat COT
gene. Therefore, the physiological function, if any, of these
maturation pathways by ‘alternative’ trans-splicing (as
opposed to ‘specialized’ trans-splicing which is a normal
mRNA maturation pathway in some organisms such as
trypanosomes and nematodes) remains to be established.
Nevertheless, the potentiality for trans-splicing does exist
in mammalian cells and RNA reprogramming strategies
based on it and aimed at therapeutic interventions have
been recently described (14).
We are interested in the role of MYC gene ampliﬁcation in
tumor cells. We have isolated two types of sub-clones from the
SW613-S human colon carcinoma cell line that exhibit either a
high or a low level of MYC gene ampliﬁcation and whose cells
disclose marked phenotypic differences (15,16). In order to
demonstrate that the level of ampliﬁcation of the MYC gene
plays a role in these phenotypic differences, stable transfect-
antswere establishedfollowingtransfectionofcellsdisplaying
a low level of ampliﬁcation with a plasmid containing a MYC
gene. The structure of the abnormal MYC mRNAs produced
by one ofthesetransfectantswas analyzed in detail. During the
course of this analysis, we uncovered very unusual pathways
of RNA maturation in these cells, involving splicing and poly-
adenylation on RNA polymerase I-generated MYC transcripts
as well as trans-splicing at a high frequency.
MATERIALS AND METHODS
Construction and analysis of the cDNA library
The cDNA library was constructed in a vector derived from
bacteriophage lambda using the ZAP-cDNA1 Gigapack1 III
Gold Cloning Kit (Stratagene). Brieﬂy, cDNA ﬁrst strand was
synthesized in the presence of methyl-dCTP on polyA
+ RNA
prepared from 2G1MycP2Tu1 cells, using the Moloney
murine leukemia virus reverse-transcriptase and a poly-dT
primercontainingaXhoI site.TheRNA templatewaspartially
digested with RNase H and the second strand of the cDNAs
was synthesized with E.coli DNA polymerase I. An adaptor
oligonucleotide containing an EcoRI site was ligated onto the
cDNA ends. After digestion with XhoI, the cDNAs were size-
fractionated by chromatography on a Sepharose CL-2B
column. The selected cDNAs were ligated to Uni-Zap XR
vector DNA digested with EcoRI and XhoI, and in vitro pack-
aging was carried out. The cDNA library contained 1.5 · 10
6
independent recombinants.
Screening of the library was performed on 200 000 recom-
binants by in situ hybridization as described by Sambrook and
Russel (17) using XL1-blue E.coli bacteria and an EcoRI/ClaI
fragment of the human MYC gene (exon 3) as a probe. More
than 500 positive clones were detected by the probe and 50 of
them were selected for further puriﬁcation and analysis. Phage
cloneswere puriﬁed by two additional rounds of insitu hybrid-
ization. Phagemids were then excised from each phage clone
by recombination in vivo in the SolR E.coli bacteria and were
used to infect XL1-blue E.coli bacteria.
Plasmids were extracted using a miniprepreparation
technique based on alkaline lysis (17) and the cDNAs were
analyzed by sequencing. Three primers were used: a 20mer
oligonucleotide corresponding to the promoter of phage T3
RNA polymerase which is located upstream of the cDNA
insert (AATTAACCCTCACTAAAGGG); a 22mer antisense
primer corresponding to the promoter of phage T7 RNA
polymerase which is located downstream of the cDNA insert
(GTAATACGACTCACTATAGGGC); a 20mer antisense
primer whose sequence is located at the beginning of exon 2
of the human MYC gene (TCCTCCTCGTCGCAGTAGAA).
This last primer allowed the determination of the cDNA
sequences located upstream of MYC exon 2. The sequences
were analyzed by comparison with the sequence of human
MYC mRNA (Align software from Scientiﬁc and Educational
Software) and by comparison with nucleic acid sequences in
public database libraries (program Blast).
Nucleic acid extraction and analysis
Nuclear, cytoplasmic and total cellular RNAs were prepared
as described by Weil et al. (18). Polyadenylated RNA was
puriﬁed by chromatography on an oligo(dT)-cellulose column
(Oligo(dT)-cellulose type 7 from Amersham Pharmacia
Biotech Inc) as previously described (19). Analysis by agarose
gel electrophoresis and northern blotting were performed as
previously reported (20). Genomic DNA was extracted and
analyzed by Southern blotting as described previously (21).
Ampliﬁcation by the PCR was performed on 1 mgo f
genomic DNA with 2.5 U of Taq polymerase (Bioprobe)
and 100 pmol of each primer in a 100-ml volume using the
reaction buffer provided by the supplier. The sense primer
(CCAGGTACCTAGCGCGTT) was designed from the
sequence of the ﬁrst internal transcribed spacer (ITS1) of
the human rDNA transcription unit and the antisense primer
(CTCCCATCTTGACAAGTC) from that of the ﬁrst intron of
the human MYC gene. The conditions for PCR were 1 min at
95 C, 1 min at 60 C and 1 min at 72 C for 30 cycles. Reverse
transcription reactions were carried out as follows: polyA+
RNA (5 mg) and random hexamers (400 ng) were mixed in
the presence of 100 mM Tris–HCl pH 8.0 and 50 mM NaCl
(ﬁnal volume 10 ml), heated for 3 min at 70 C, and left to
annealbycoolingfor30minatroomtemperature.Themixture
was then adjusted to a volume of 30 ml containing 50 mM
Tris–HClpH8.0,16.6mMNaCl,37.5mM KCl,5mMMgCl2,
10 mM DTT, 125 mM each dNTP, 100 mg/ml bovine serum
albumin, 1500 U/ml rRNasin (Promega), and 1000 U of
M-MLV reverse transcriptase (Promega) and incubated for
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each PCR assay which was performed in a 100-ml volume
under the conditions described above but for 40 cycles.
The sense (ACGGAGATCACCATCGTCAA) and antisense
(TGCTGCTGCTGGTAGAAGTT) primers were designed
from the sequence of exon 2 of the human MSF and MYC
genes, respectively. Aliquots (40 ml) of the ampliﬁcation
reactions were analyzed by agarose gel electrophoresis.
Fluorescent in situ hybridization
Chromosome metaphase spreads were prepared from cultured
SW613-2G1 and 2G1MycP2Tu1 cells, using standard meth-
ods. Lymphocytes from normal individuals were used as a
control. Fluorescent in situ hybridization (FISH) experiments
were performed as previously described (22). The MYC probe
was prepared from cosmid K880, which contains a 35 kb
human genomic insert encompassing the MYC gene (23).
Puriﬁed cosmid DNA was labeled by nick translation in the
presence of digoxigenin-dUTP, mixed with Cot1 human DNA
and sonicated salmon sperm DNA, and used for hybridization.
After washing, the slides were incubated with a Rhodamine-
labeled anti-digoxygenin antibody (Qbiogene), yielding a red
ﬂuorescent signal. This probe reveals the expected locus
(8q24) on normal chromosome metaphases. The rDNA
genomic probe was derived from BAC clone CIT-HSP
2505H6 obtained from the Genoscope (Evry, France). This
BAC clone contains several copies of the whole 43 kb rDNA
unit (18S-5.8S-28S-intergenic spacer). Puriﬁed BAC DNA
was labeled by random priming in the presence of Alexa
488-dUTP (Molecular Probes), producing a green ﬂuorescent
signal. On normal metaphases, this probe hybridized to the
short arm of all acrocentric chromosomes (13,14,15,21 and
22), yielding signals of variable intensities, depending on
the locus. For each hybridization experiment,  20 metaphase
images were acquired with a Vysis station (Downers Grove,
IL, USA) using the Quips Smart Capture FISH Imaging
software.
RESULTS
Chimeric transcripts in 2G1MycP2Tu1 cells
Stable transfectants were obtained after transfection of cells
from clone 2G1 (displaying a low level of ampliﬁcation of
MYC) with a plasmid carrying an 8 kb fragment of genomic
DNA encompassing the MYC gene. Two of these transfect-
ants produce large amounts of MYC mRNAs and proteins
of abnormal size. We wondered whether these abnormal
mRNAs were responsible for the abnormal pattern of MYC
proteins observed in these cells, and whether this unusual
pattern of expression of the MYC gene has a role in the pheno-
typic properties acquired by these cells. To address these
questions, we analyzed in detail the structure of the abnormal
MYC mRNAs produced by one of the two transfectants, the
2G1MycP2Tu1 cell line.
A cDNA library constructed using RNA isolated from
2G1MycP2Tu1 cells was screened with a MYC probe (third
exon). Fifty positive clones were sampled, puriﬁed and ana-
lyzed by DNA sequencing. The isolated MYC cDNAs could
be classiﬁed into three groups. The cDNAs of the ﬁrst group
(11 clones) consist of MYC exons 2 and 3 fused to upstream
rDNA sequences. The second group (35 clones) contains
chimeric cDNAs composed of exons 2 and 3 of the MYC
gene fused in 50 to one or several exons from another gene.
The third group is represented by cDNAs containing a trun-
cated MYC exon 2 of variable length spliced to MYC exon 3.
The latter were probably derived from mRNAs that had not
been fully retro-transcribed and, as such, were not studied
further.
2G1MycP2Tu1 cells harbor a chimeric rDNA-MYC gene
The rDNA-MYC fusion cDNAs were of two different types.
One type is represented by clones 13 and 21 (Figure 1A). The
rDNA sequences found upstream of the MYC exons are com-
posed of a truncated ITS1 (Internal Transcribed Spacer 1)
region and, in the case of clone 21, of an almost complete
18S region. The 18S and ITS1 sequences of clone 21 are con-
tiguous like in a normal rDNA transcription unit. These rDNA
sequences are fused to a truncated MYC exon 1, which is itself
splicedtoexon2.ThelatterisproperlysplicedtoMYCexon3.
A likely explanation for these observations is that integration
of a copy of the MYC plasmid occurred in the ITS1 region of
one of the rDNA transcription units of 2G1MycP2Tu1 cells.
The junction points, localized at position 6163 of the rDNA
transcription unit and at position 2855 of the MYC gene, have
no noticeable feature, suggesting that the fusion occurred by
illegitimate recombination following transfection.
To conﬁrm this hypothesis, we ought to identify the expec-
ted junction in the genomic DNA of 2G1MycP2Tu1 cells.
An ampliﬁcation by PCR was carried out using as a template
genomic DNA extracted from cells of the 2G1MycP2Tu1
and 2G1 cell lines. The sense primer was located in the ITS1
region and the antisense primer hybridized to MYC intron 1
(Figure 2A). As predicted, a fragment of 273 nt was ampliﬁed
from2G1MycP2Tu1DNAbutnotfrom2G1DNA(Figure2B).
As a positive control, a fragment corresponding to the APC
gene could be ampliﬁed from both DNAs with the appropriate
primers. The PCR fragment obtained with 2G1MycP2Tu1
DNA was cloned and sequenced. Its sequence was identical
to that of cDNA clones 13 and 21 in the region encompassing
the junction point (ITS1 and MYC exon 1) (Figure 2A). To
conﬁrm that a copy of the MYC gene did integrate into one of
the rRNA gene clusters, FISH experiments were performed on
metaphase chromosomes from 2G1 and 2G1MycP2Tu1 cells
(Figure 3). In the parental 2G1 cells, a MYC probe detects a
unique copy of the MYC gene carried on a single chromosome
8 and ampliﬁed copies of the gene located in an HSR (homo-
geneously staining region). 2G1MycP2Tu1 cells have MYC
copies integrated into two additional chromosomal sites: one
on a marker chromosome (mkB) and one on the short arm
of a derivative of chromosome 13 (13p+). The identity of this
chromosome was checked by chromosome painting experi-
mentsusingachromosome13-speciﬁcprobe(datanotshown).
This last site of integration is one of the known locations of
rRNAgenes inhumancells(24).FISH experimentscarriedout
with an rDNA probe conﬁrm the co-localization of MYC gene
copies and rRNA genes at the 13p+ site (Figure 3). The MYC
and rDNA signals also co-localize in FISH experiments car-
ried out with interphase nuclei (data not shown), conﬁrming
the molecular proximity of the corresponding sequences.
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MYC gene are inserted into an rDNA transcription unit.
Structure of rRNA-MYC fusion transcripts
The second type of rDNA-MYC cDNAs is represented by nine
different clones (Figure 1A). The 50 region of these cDNAs
consists ofsequences ofvariouslengthderived from the 50ETS
Figure 1. Structure of chimeric rDNA/MYC cDNAs. (A) Schematic
representation of the structure of 11 cDNA clones deduced from sequencing
analysis. Boxes in light and dark gray represent rDNA and MYC sequences,
respectively.ITS1,internaltranscribedspacer1;50ETS,50 externaltranscribed
sequence;EX,exon;canandalt,canonicalandalternativespliceacceptorsiteof
MYC exon 2. ‘D’ indicates that the corresponding sequence is truncated.MYC
exon1D is only 27 nt long. Base pair coordinates are given relative to the
transcription unit for rDNA sequences (accession no. U13369) and to the
genomic sequence (accession no. D10493) for MYC. The dotted line limiting
the 50ETS box between positions 430 and 665 delineates the beginning of the
longest and the shortest of the nine cDNA clones. (B) Sequences of the rDNA
50ETS and of the MYC gene encompassing the cryptic splice donor site and
the acceptor site of exon 2, respectively. Consensus sequences for donor and
acceptor sites are shown below, with double-headed arrows indicating the
cleavage sites. The lower part of the figure shows the sequences of hybrid
mRNAs after either canonical or alternative splicing.
Figure 2. Detection of the MYC–rDNA junction by genomic PCR. (A) DNA
sequence encompassing the junction point between the MYC gene and the
rDNA transcription unit. Gray arrows indicate the position of the primers used
for genomic PCR. Symbols and coordinates are as in Figure 1. The junction
point between ITS1 and MYC exon 1 is indicated by an I-shaped line and the
border between MYC exon 1 and intron 1 by a vertical line. (B) Genomic PCR
was performed on DNA extracted from 2G1 (lane 1) or 2G1MycP2Tu1 cells
(lane 2). Arrows point to the 273 bp amplified fragment obtained using the
primersshownin(A)andtothe126bpfragmentamplifiedfromtheAPCgene.
The size of the DNA fragments used as molecular weight markers is indicated
on the right.
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ent clones, this 50ETS sequence is more or less truncated in 50
(starting at position 430–665) but, in all clones, it ends at
position 1018 and is fused to MYC exon 2. The latter is pro-
perly spliced to MYC exon 3. The human MYC gene has two
splice acceptor sites at the 50 end of exon 2: one so-called
‘canonical’ site (at position 4507) and one ‘alternative’ site (at
position 4510). Exon 1 is spliced to the canonical versus
alternative splice site of exon 2 in  70% and 30% of MYC
mRNAs, respectively (25). For 8 out of the 9 cDNA clones,
the 50ETS sequence is exactly joined to the canonical site of
MYC exon 2 and for the remaining one, it is joined to the
alternative site. This strongly suggests that the corresponding
transcripts have been generated by a splicing event occurring
between a cryptic splice donor site in the 50ETS region (at
position 1018) and one of the MYC splice acceptor sites of
exon 2 (Figure 1B). Indeed, the sequence of the 50ETS region
around position 1018 does match the consensus sequence for a
splice donor site (26) including the hallmark GT dinucleotide
at positions 1019 and 1020.
Cytoplasmic polyadenylated RNA from 2G1MycP2Tu1
cells was analyzed by northern blotting using a MYC exon
3 probe (Figure 4). As expected, RNAs of abnormal size are
detected (11, 9, 4.6 kb and a smear between 2.7 and 2.1 kb as
compared to 2.4 kb for MYC mRNAs in parental 2G1 cells).
On short exposures (data not shown), two clusters of RNAs at
2.1 and 2.7 kb can be distinguished within the smear. The 11
and 9 kb RNAs are revealed by both a 50ETS and an ITS1
probe. The 4.6 and 2.7 kb bands are detected only by an ITS1
or a 50ETS probe, respectively. A probe corresponding to
MYC intron 1 hybridizes exclusively to the 11 kb RNA
(Figure 5). These results indicate that chimeric rRNA-MYC
RNA molecules are indeed synthesized in 2G1MycP2Tu1
cells and that these species are polyadenylated. This was con-
ﬁrmed by comparative quantitative analysis of total RNA,
polyA
+ RNA and polyA
  RNA from 2G1MycP2Tu1 cells
by northern blotting with a MYC probe. The polyA
+ fraction
was enriched 12-fold in chimeric RNAs as compared to total
RNA whereas these species were 2-fold less abundant in the
polyA
  fraction than in total RNA. The corresponding ﬁgures
for the keratin 18 mRNA, used as an internal control, were
13-fold and 3-fold, respectively (data not shown). The nuc-
leocytoplasmic distribution of the chimeric RNAs was studied
on northern blots prepared with cytoplasmic and nuclear
RNA (Figure 5). The high molecular weight species (11, 9
and 4.6 kb)predominate inthe nuclear fraction. In contrast,the
2.1–2.7 kb RNAs are more abundant in the cytoplasm.
Figure 3. Chromosomal localization of MYC gene copies in 2G1 and
2G1MycP2Tu1 cells. FISH experiments were performed with a MYC probe
(red)on2G1(parentalcells)and2G1MycP2Tu1(transfectant)metaphasesand
with an rDNA probe (green) on 2G1MycP2Tu1 metaphases. chr8: resident
MYC gene; HSR: amplified copies of the MYC gene localized in an HSR;
13p+: co-localization of the exogenous copies of the MYC gene and of rRNA
genes on a rearranged chromosome 13 short arm; mkB: insertion of exogenous
copiesoftheMYCgeneintoanunidentifiedmarkerchromosome.Notethatthe
rDNA probe reveals, as expected,additionalrDNA copies on other acrocentric
chromosomes (green spots).
Figure 4. Abnormal MYC mRNAs in 2G1MycP2Tu1 cells. Polyadenylated
RNA from 2G1MycP2Tu1 (lanes 1–3) or 2G1 (lane 4) cells was analyzed
by northern blotting using a MYC exon 3 probe (lanes 1 and 4), a 50ETS probe
(lane 2) or an ITS1 probe (lane 3). Exposure time for lane 4 was 9 times longer
than for the other lanes. Arrows on the left point to MYC mRNAs and arrow-
heads on the right indicate the position of rRNAs. Polyadenylated RNA pre-
parations were not completely pure so that 45S, 32S and 28S rRNAs were
visible in these samples with the rDNA probes. Detection of the 32S rRNA by
the 50ETS probe and of the 28S rRNA by the 50ETS and ITS1 probes is due to
cross-hybridization.
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fusion transcripts
From all the results presented above, we infer a model that
can explain how the rRNA-MYC chimeric transcripts are
produced in 2G1MycP2Tu1 cells. A copy of the MYC gene
has integrated into one of the rDNA transcription units of the
genome (Figure 6A) at position 6163 within the ITS1 region
and the MYC gene was truncated at position 2855, with
deletion of the 50 upstream sequences (Figure 6B, ﬁrst line).
This resulted in a chimeric transcription unit whose primary
transcript is  11 000 nt long. This primary transcript could
correspond to the 11 kb RNA observed on northern blots,
which is detected by the 50ETS, ITS2, MYC intron1 and
MYC exon 3 probes and which is essentially located in the
nucleus. From this primary transcript, two maturation path-
ways are possible. In the ﬁrst one, both introns of the MYC
gene are spliced out and a cleavage occurs between the 50ETS
and 18S regions, as it is the case during maturation of the
normal 45S ribosomal RNA precursor (Figure 6B, pathway 1).
This leads to the production of a chimeric 4.3 kb RNA from
which the cDNA clones 13 and 21 would be derived. This
RNA could correspond to the 4.6 kb band observed on north-
ern blots which is revealed by both the ITS1 and MYC exon 3
probes (Figure 4). This RNA species is inefﬁciently transpor-
ted to the cytoplasm. It is also probably very inefﬁciently
translated, if at all, since its 50 untranslated region is very
long and composed of 18S and ITS1 sequences which are
known to fold into many stem–loop secondary structures (27).
In the second maturation pathway, the primary transcript
is spliced between a cryptic donor site located in the 50ETS
region (at position 1018) and MYC exon 2 acceptor sites
(canonical or alternative). The MYC intron 2 is spliced out
in a normal way (Figure 6B, pathway 2). The resulting
chimeric RNA is composed of the 50 half of the 50ETS region
Figure 5. NucleocytoplasmicdistributionofchimericMYCmRNAs,Northern
blot analysis was performed on 10 mg of nuclear (lanes N) or cytoplasmic
(lanes C) RNA extracted from 2G1MycP2Tu1 cells. An MYC exon 3 or
intron 1 probe was used, as indicated. Symbols are as in Figure 4.
Figure6.PossiblematurationpathwaysforthehybridrRNA/MYCtranscripts.(A)ThestructuresoftherDNAtranscriptionunitandoftheMYCgenearerepresented
respectively by light and dark gray boxes. The position of the MYC gene promoters (P0, P1 and P2) and polyadenylation sites (pA1 and pA2) is indicated. (B) Two
possible maturation pathways (1 and 2) are indicated by bold arrows. The approximate calculated size of the different transcripts is given on the right. 30ETS, 30
external transcribed spacer. Other symbols and coordinates are as in Figure 1.
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The nine cDNAs with such a structure (Figure 1A) would be
derived from this transcript. This RNA could correspond to
the 2.7 kb band revealed by both the 50ETS and MYC exon 3
probes on northern blots (Figure 4). This species is efﬁciently
exported to the cytoplasm.
Transcription of the chimeric rDNA-MYC gene by
RNA polymerase I
The existence of a chimeric rDNA-MYC gene in
2G1MycP2Tu1 cells raises the question of the nature of
the RNA polymerase that transcribes it. From the structure
of this chimeric gene (Figure 6B), one would expect that RNA
polymerase I drives its expression. To address this question,
the sensitivity to actinomycin D of the polymerase responsible
for the synthesis of abnormal MYC mRNAs was assayed.
2G1MycP2Tu1 cells were treated for seven hours with the
drug and the level of MYC mRNAs was analyzed on northern
blots (Figure 7A). The synthesis of these mRNAs was inhib-
ited by 80–95% in the presence of 0.03 mg/ml of actinomycin
D. Such a sensitivity to low doses of this drug is characteristic
of RNA polymerase I transcription (28). Accordingly, a sim-
ilar dose–response curve was observed for the 45S ribosomal
RNA precursor (Figure 7B). In contrast, RNA polymerase II
transcription requires higher doses of actinomycin D for
inhibition, as exempliﬁed by FGF3 (ﬁbroblast growth factor)
gene expression for which an inhibition of 85% is reached at
no less than 1 mg/ml of actinomycin D. It is also noteworthy
that 2G1MycP2Tu1 cells produce a small amount of appar-
ently normal MYC mRNAs (2.4 kb) whose accumulation is
insensitive to low doses of actinomycin D. These mRNAs are
presumably derived from the resident gene copies which
are transcribed by RNA polymerase II. From all these results,
we conclude that the RNAs derived from the chimeric
rDNA-MYC gene in 2G1MycP2Tu1 cells are synthesized by
RNA polymerase I.
Trans-spliced mRNAs in 2G1MycP2Tu1 cells
The second group of chimeric MYC cDNAs comprises 35
different clones. They are composed of one or more exons
coming from another gene, spliced to MYC exon 2 which is
itself normally spliced to exon 3. Such a gene was dubbed
‘exon-donor’. Out of the 35 cDNAs analyzed, we identiﬁed 33
different exon-donor genes which are located on 14 different
chromosomes (Table 1). The non-MYC exons are spliced
either to the canonical or to the alternative acceptor splice
site of MYC exon 2. For each exon-donor gene, the genomic
sequence was examined and, in all cases, the sequence at the
junction point matched the consensus sequence for a splice
donor site (data not shown). These observations indicate that
the mRNAs corresponding to the 33 different cDNA clones
were generated by a bona ﬁde splicing mechanism.
A possible explanation would be that extensive integration
of introduced MYC gene copies occurred at many chromo-
somal sites in 2G1MycP2Tu1 cells. At each of these sites, the
MYC gene copy would have integrated in such a way that
a chimeric exon-donor-MYC gene would be created, similar
to the chimeric rDNA-MYC gene described above. Chimeric
transcripts could then be generated by cis-splicing of the
primary transcripts produced by such genes. This hypothesis
seemed highly unlikely to us but experiments were devised to
formally rule it out. If a copy of the MYC gene has integrated
into an exon-donor gene downstream of the exon which is
spliced to MYC exon 2, this should result in a rearrangement
of one allele of the gene. The structure of three ‘exon-donor’
genomic loci in 2G1 and 2G1MycP2Tu1cells was analyzed
by Southern blotting: the laminin gamma C3 gene (LAMC3),
the DNA polymerase a gene (POLA2) and a gene coding for
a putative protein (FLJ14775) (Figure 8A). In each case,
Figure 7. Sensitivity of MYC mRNA synthesis to actinomycin D in
2G1MycP2Tu1 cells. (A) 2G1MycP2Tu1 cells were incubated for 7 h in the
presence of the indicatedconcentrationsof actinomycin D. Total cellularRNA
was extracted and analyzed by northern blotting using an MYC exon 3 probe
(upper panel), an rDNA 50ETS probe which reveals the 45S ribosomal RNA
(middle panel) or an FGF3 probe (lower panel). Symbols are as in Figure 4.
(B) Quantification of the results shown in (A). Hybridization signals were
quantified as described (30), and the results are expressed as the percentage
ofinhibitionofthesynthesisofeachRNAspeciesrelativetothezerotimepoint.
2338 Nucleic Acids Research, 2005, Vol. 33, No. 7the restriction enzyme was chosen so as to generate a restric-
tion fragment encompassing the whole intron containing the
putative site where insertion of the MYC gene should have
occurred. In all three cases, the alleles of the exon-donor gene
are in a germ-line conﬁguration in the region analyzed, in both
2G1 and 2G1MycP2Tu1 cells. These results do not support the
integration hypothesis, at least for these three genes. Further-
more, FISH experiments performed with a MYC probe indi-
cated that there are only two new MYC gene integration sites
in 2G1MycP2Tu1 cells, as compared to 2G1 cells (Figure 3).
This isnot consistent with our ﬁnding that the non-MYC exons
originate from 33 different exon-donor genes.
An alternative possibility would be that recombination
events leading to cellular heterogeneity take place in the
2G1MycP2Tu1 cell line, resulting in the appearance of sub-
populations of cells bearing genomic fusions of the MYC gene.
If these subpopulations are minority, they would not be detec-
ted by Southern or FISH analysis. To address this question,
we derived sub-clones from the 2G1MycP2Tu1 cell line and
attempted to detect the presence of the MSF-MYC fusion
transcript (Table 1) in these cells. Reverse transcription-PCR
reactions carried out with polyA
+ RNA prepared from three
sub-clones revealed that they all produce this chimeric tran-
script (Figure 8B). This result does not support the hypothesis
that this transcript is produced by a minority subpopulation of
2G1MycP2Tu1 cells harboringan exogenousMYC gene integ-
rated in the resident MSF gene. The most likely explanation
for all these observations is that the chimeric MYC mRNAs
with extraneous exons were generated by splicing events
occurring in trans, between pre-mRNAs derived from one
of the exon-donor gene and from a MYC gene copy. Therefore,
we conclude that trans-splicing occurs at high frequency in
cells of the 2G1MycP2Tu1 cell line.
DISCUSSION
Uncoupling of pre-mRNA processing from
transcription
We have found that the 2G1MycP2Tu1 cell line, isolated
following transfection of 2G1 cells with a plasmid carrying
the MYC gene, harbors a truncated copy of this gene integrated
into an rDNA transcription unit. This results in the production
of chimeric rRNA-MYC transcripts that are synthesized by
RNApolymeraseI.Thesetranscriptsareoftwodifferenttypes,
depending on the rRNA sequences found at their 50 end (50ETS
or 18S/ITS1). We propose that they are derived from the
chimeric primary transcript by two different maturation path-
ways (Figure 6) involving normal splicing of the MYC introns
and maturation by cleavage of the rRNA sequences
(pathway 1) or splicing between a cryptic donor site in the
50ETS sequence and one of the acceptor sites of MYC exon 2
(pathway 2). Since the putative end-products of these two
pathways (4.6 and 2.7 kb mRNAs, respectively) accumulate
to comparable amounts in the cells, the 50ETS cryptic donor
site appears to be used as efﬁciently as the donor site of MYC
exon 1 during maturation of the chimeric transcript. Although
the intrinsic efﬁciency of the 50ETS site is unknown, it is
possible that the efﬁciency of the natural donor site of
MYC exon 1 is impaired because of the proximity (27 nt)
of the junction point with rRNA sequences which might
fold into highly ordered secondary structures. Another non-
exclusive possibility is that splicing is not coupled with tran-
scription during the synthesis of these transcripts because the
splicing machinery cannot associate with RNA polymerase I.
Thus, splicing would necessitate relocalization of the primary
transcript, presumably from the nucleolus to the splicing
machinery in the nucleoplasm and the use of the cryptic
site could be enhanced during this process.
Table 1. Features of exon-donor genes
Chromosomal
localization
a
Gene
name
b
Spliced
exons
c
MYC
splicing
site
d
1p34.2 NFYC ex 2 can
1p36.13 i
10.21 Mb (4.2 %) AJ749659 One exon can
1p36.31 i
4.20 Mb (1.7%) ESPN ex 7b can
1p36.33 SKI ex 1 can
2p11.2 AJ749662 One exon alt
2q11.2 MAP4K4 ex 2 can
2q14.2 RALB ex 1 can
3p22.2 
5.48 Mb (2.7%) ACVR2B ex 1 can
3p23 GLB1 ex 1 can
4p16.3 KIAA1530 ex 1 to 7 can
4q24 AJ749663 One exon can
5p15.33 BF508938
(EST)
ex 1 alt
5q31.1 
5.59 Mb (3.4%) TCF7 ex 2 can
5q31.3 AJ749665 One exon alt
7q21.2 CDK6 ex 1 alt
7q21.2 
6.86 Mb (4.3 %) CDK6 ex 1 can
7q22.1 FLJ12298 ex 1+2+4+5 can
9q22.2 CKS2 ex 1 alt
9q34.13 LAMC3 ex 1 alt
11q13.1 
3.19 Mb (2.4 %) POLA2 ex 1+9 to 17 can
11q13.2 LRP5 ex 6 can
14q32.11 CHES1 ex 1, 1b and 2 alt
14q32.33 BF309232
(EST)
ex 1 can
16p12.1 AJ749661 Two exons can
16p13.3 
1.46 Mb (1.6 %) FLJ14154 ex 1 can
16p13.3 PKD1 ex 1 can
17q25.3 
4.29 Mb (5.3 %) MSF ex 2 can
17q25.1 FLJ14775 ex 1 can
19p13.3 BC014506
(mRNA)
ex 2+3 can
21q22.3 
0.86 Mb (1.8 %) PDXK ex 1b+ex 2 can
21q22.3 D21S2056E ex 9 to 12 can
22q11.1 FLJ 31573 ex 7 alt
Repeated sequence Four exons alt
Repeated sequence One exon can
aAccordingtotheUCSCGenomeBrowser,July2003assembly(http://genome.
ucsc.edu).Thedistancebetweensomelocationsisgiveninmegabases(Mb)and
asapercentageofthelengthofthecorrespondingchromosome(NCBIbuilt34).
bFor exons corresponding to ESTs or mRNAs previously described but not
presently assigned to a known gene, the accession number is indicated. Acces-
sion numbers for the sequences determined in this work are EST BF508938:
AJ749664; EST BF309232: AJ749660. Accession numbers in italics refer to
exonsthatwerenotpreviouslyfoundinanESTormRNAandarelocalizedina
region of the human genome with no recorded gene (July 2003 assembly).
cExons(ex)denotedbybhavenotbeenreportedpreviouslyforthecorrespond-
ing gene. Their number is derived from that of the preceding exon. Accession
numbers for the corresponding sequences are: ESPN: AJ749667; CHES1:
AJ749666; PDXK: AJ749668.
dcan: canonical; alt: alternative. Note that for the CDK6 gene two different
cDNAs were isolated, corresponding to canonical or alternative splicing on
MYC exon 2. Two cDNA clones with an identical structure were isolated for
the NFYC gene.
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from transcription in vivo. Few data are available and contra-
dictory results have been reported (see Introduction). Since the
chimeric rRNA-MYC transcripts produced by 2G1MycP2Tu1
cells are polyadenylated and since there is no evidence that
RNA polymerase I can associate with 30 end processing
factors, our results are in favor of a possible uncoupling of
the two processes. It is worth mentioning that these results
were obtained in a system where the studied gene is stably
integrated into a chromosomal site whereas previously
Figure 8. Analysis of four genomic loci in 2G1 and 2G1MycP2Tu1 cells. (A) Genomic DNA from 2G1 (lane 1) or 2G1MycP2Tu1 (lane 2) cells was analyzed by
Southernblottingusinga laminingamma3(LAMC3)probe, a DNApolymerasealphasubunitB(POLA2)probeora probecorrespondingto thegeneencodingthe
putative protein FLJ14775. The restriction enzyme used in each case is indicated at the bottom of each panel. Arrows point to the hybridizing fragment of interest
whosesizeisindicatedinbasepairs.NotethatthePOLA2proberevealsadditionalgenomicDNAfragmentssinceitcontainsseveralexons.ThepositionoftheDNA
fragments used as molecular weight markers is indicated on the right. The structure of the corresponding chimeric cDNAs is shown with MYC exons 2 and 3
symbolizedbydarkgrayboxesandexonsfromtheexon-donorgenes(LAMC3,POLA2orFLJ14775)bylightgrayboxes.Thegenomicstructureofthesethreegenes
inthevicinityoftheexonsfoundinthechimericcDNAsisschematizedatthebottomofthefigurewiththepositionoftherestrictionenzymesitesofinterestandthe
size of the resulting fragments indicated below. The exons marked with a star are those included in the cDNA fragment used as a probe. (B) PolyA+ RNA prepared
from 2G1MycP2Tu1 (lane 2), 2G1MycP2Tu1-clone 2, -clone3, -clone 4 (lanes 3–5), and 2G1 (lane 6) cells was reverse-transcribed in the presence of random
hexamers. Amplification by PCR was carried out in the absence (lane 1) or in the presence (lanes 2–6) of the corresponding cDNAs. Arrow points to the 396 bp
amplifiedfragmentobtainedusingprimerslocatedinexon2ofthehumanMSFandMYCgenes.ThesizeoftheDNAfragmentsusedasmolecularweightmarkersis
indicated on the right.
2340 Nucleic Acids Research, 2005, Vol. 33, No. 7reported results (3,5) were obtained with transient expression
assays.
As far as we know, there is no data available on the possible
uncoupling of splicing from transcription in vivo. Such a
situation may exist in trypanosomes since splicing of RNA
polymerase I transcripts has been reported in these organisms
[reviewed in (6)] and since this polymerase is presumably
unable to recruit the splicing machinery but this concerns a
peculiar situation of trans-splicing. We provide here evidence
that the chimeric rRNA-MYC transcripts synthesized by
RNA polymerase I in 2G1MycP2Tu1 cells are processed in
these human cells through bona ﬁde splicing events. Thus, our
results indicate that splicing may be uncoupled from RNA
polymerase II transcription in mammalian cells.
High frequency trans-splicing in human cells
Our analysis of the structure of cDNA clones reveals the
presence in 2G1MycP2Tu1 cells of many different hybrid
transcripts consisting of one or more 50 exons, originating
from more than 30 different exon-donor genes and correctly
spliced to MYC exon 2, itself properly spliced to exon 3. The
donor site of the foreign exon is joined to one or the other of
the two functional alternative acceptor sites of exon 2 of the
human MYC gene. We propose that these molecules are gen-
erated by trans-splicing events occurring at a relatively high
frequency in these cells. Indeed, we have ruled out the pos-
sibilitythatnumerousdifferentintegrationeventstookplacein
these cells. The cDNA clones corresponding to mRNAs gen-
erated by trans-splicing were as abundant in the library as the
chimeric rDNA-MYC clones. Since the hybrid rRNA-MYC
mRNAs accumulate to a high level in 2G1MycP2Tu1 cells
(see Figure 4), trans-splicing events should occur at a high
frequency in these cells. On northern blots, a MYC probe
detects a group of abundant mRNAs with an average size of
2.1 kb (Figure 4). These molecules are not revealed by any of
the rDNA probes used. They probably correspond to at least
part of the hybrid mRNAs generated by trans-splicing. Can
these hybrid mRNAs be translatedinto chimeric proteinswhen
open reading frames are joined in phase? It is likely because
western blots prepared with protein extracts from these cells
and probed with an anti-MYC antibody disclose the presence
of a group of abnormal MYC proteins of higher molecular
weights (C. Chen, unpublished results). These proteins are not
present in the parental 2G1 cell line.
Are the trans-spliced MYC mRNA molecules derived from
the same MYC gene copy and primary transcripts as the hybrid
rRNA-MYC mRNAs? This seems most likely to us since the
synthesisofthe 2.1kbmRNAs isassensitive toactinomycinD
inhibition as that of the rRNA-MYC transcripts (Figure 7A).
In this case, trans-splicing would also be uncoupled from
transcription in 2G1MycP2Tu1 cells, as postulated above for
50ETS-MYC mRNA cis-splicing. As mentioned above, one
may speculate that this uncoupling is a consequence of a
relocalization of the nucleolar primary transcript to the spli-
cing machinery, a process that could favor the occurrence of
splicing events in trans. It is also possible that the inefﬁciency
of the cis-splicing reaction involving the MYC exon 1 donor
site, due to the proximity of the junction point with rRNA
sequences, favors splicing in trans. The high level of chimeric
rRNA-MYC primary transcripts in 2G1MycP2Tu1 cells, due
to the strength of the rDNA promoter may also contribute
to increase the frequency of trans-splicing. Finally, it is
also possible that a cryptic sequence element present in the
rRNA moiety of the chimeric rRNA-MYC primary transcripts
enhances the efﬁciency of trans-splicing. Sequence elements
playing a role in trans-splicing have been described (11,29).
A better knowledge of the elements of the chimeric rDNA-
MYC gene that are responsible for the high efﬁciency of
trans-splicing could help in the design of a vector aimed at
RNA reprogramming strategies, in particular those using
spliceosome-mediated RNA trans-splicing (14).
The foreign exons splicedtoMYCexon 2are most probably
derived from primary transcripts synthesized by RNA
polymerase II on the exon-donor genes and, therefore, are
capped at their 50 end. The situation in 2G1MycP2Tu1 cells
is reminiscent of that in trypanosomes. In these organisms, the
maturation of uncapped transcripts synthesized by RNA poly-
merase I naturally occurs by trans-splicing (6). This allows
these transcripts to have a capped 50 end which is necessary
for efﬁcient translation. It has been reported that uncapped
mRNAs synthesized by RNA polymerase I in yeast are
very inefﬁciently translated (4). We have identiﬁed more
than 30 exon-donor genes and many more must exist since
most of them were identiﬁed through the isolation of a single
cDNA clone. Are trans-splicing events occurring at random
in 2G1MycP2Tu1 cells and, if so, is the selection of foreign
exons only governed by the probability of encounter, i.e. the
abundance of the exon-donor gene primary transcripts? Most
probably not. Indeed, we did not isolate any hybrid cDNAs
containing exons from genes known to be expressed at a high
level in our cells such as the keratin 8 and 18 genes, the b-actin
gene or the ferritin-H gene. In contrast, we isolated cDNA
clones containing exons from genes that are likely to be
expressed at much lower levels: transcription factors NFYC
or TCF7, DNA polymerase a (POLA2), for example. An
important parameter for the selection of the source of foreign
exons could be the regional intranuclear localization of the
genes. Indeed, in eight cases we identiﬁed exon-donor genes
which are close to one another on a chromosomal scale: they
are separated by a distance representing from <2% to  5% of
the total length of the chromosome (Table 1). Furthermore, it
is noteworthy that three exon-donor genes have a pericentro-
meric localization and eight of them a subtelomeric one. It is
therefore possible that the regional organization of the genes
inside the nucleus, which governs the localization of the prim-
ary transcripts, plays a role in the selection of the genes that
can be donors of exons in trans-splicing reactions. Horiuchi
et al. (10) proposed that, in Drosophila, trans-splicing occurs
locally and is dependent on chromosome proximity.
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